ArticleJournal of gastrointestinal oncology2026
Association of the global inflammatory-nutritional index (GINI) with time to next treatment and overall survival in patients with metastatic colorectal cancer receiving third-line therapy: a real-world retrospective study.
Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammation and immuno-nutritional status are key determinants of tumor progression and therapeutic resistance in metastatic colorectal cancer (mCRC). This study aimed to assess the prognostic performance of composite biomarker global inflammatory-nutritional index (GINI), which integrates multiple inflammatory, immune, and nutritional parameters, for predicting time to next treatment (TTNT) and overall survival (OS) in real-world mCRC patients receiving third-line therapy. Methods: A comprehensive analysis was performed on 320 mCRC patients hospitalized at Shanghai Municipal Hospital of Traditional Chinese Medicine. Demographic data, vital signs, laboratory results, and diagnostic information were collected. Clinical characteristics were compared across GINI tertiles high GINI group (H group), moderate GINI group (M group), and low GINI group (L group). Kaplan-Meier survival analysis, Cox proportional hazards regression, time-dependent receiver operating characteristic (ROC) analysis, and restricted cubic spline (RCS) modeling were applied to systematically characterize the association between GINI and mortality, with subgroup analyses conducted accordingly. Results: Significant differences were identified in 1-, 3-, and 5-year mortality rates across the three groups (P<0.05). Cox proportional hazards modeling indicated that GINI was a significant predictor of OS, with a statistically significant survival difference between the H and L groups (P<0.05). RCS modeling demonstrated a significant linear association between GINI and OS (P Conclusions: GINI is significantly associated with overall mortality risk and TTNT following third-line therapy in mCRC and may serve as a clinically informative indicator for prognostic assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.